Minerva Neurosciences Valuation
| NERV Stock | USD 3.90 0.29 6.92% |
At this time, the firm appears to be fairly valued. Minerva Neurosciences secures a last-minute Real Value of $3.97 per share. The latest price of the firm is $3.9. Our model forecasts the value of Minerva Neurosciences from analyzing the firm fundamentals such as Current Valuation of 169.03 M, shares owned by insiders of 22.25 %, and Return On Equity of -6.75 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Minerva Neurosciences' valuation include:
Fairly Valued
Today
Please note that Minerva Neurosciences' price fluctuation is risky at this time. Calculation of the real value of Minerva Neurosciences is based on 3 months time horizon. Increasing Minerva Neurosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Minerva stock is determined by what a typical buyer is willing to pay for full or partial control of Minerva Neurosciences. Since Minerva Neurosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Minerva Stock. However, Minerva Neurosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.9 | Real 3.97 | Target 4.0 | Hype 3.91 | Naive 3.56 |
The intrinsic value of Minerva Neurosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Minerva Neurosciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Minerva Neurosciences helps investors to forecast how Minerva stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Minerva Neurosciences more accurately as focusing exclusively on Minerva Neurosciences' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Minerva Neurosciences' intrinsic value based on its ongoing forecasts of Minerva Neurosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Minerva Neurosciences' closest peers.
Minerva Neurosciences Cash |
|
Minerva Neurosciences Total Value Analysis
Minerva Neurosciences is now projected to have valuation of 169.03 M with market capitalization of 26.92 M, debt of 60 M, and cash on hands of 40.22 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Minerva Neurosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
169.03 M | 26.92 M | 60 M | 40.22 M |
Minerva Neurosciences Asset Utilization
One of the ways to look at asset utilization of Minerva is to check how much profit was generated for every dollar of assets it reports. Minerva Neurosciences secures a negative usage of assets of -0.26 %, losing $0.002582 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Minerva Neurosciences shows how discouraging it operates for each dollar spent on its assets.Net Income | First Reported 2012-12-31 | Previous Quarter -3.3 M | Current Value -2.7 M | Quarterly Volatility 9.1 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Net Profit Margin | 0.0377 | 0.0424 |
|
| |||||
| Operating Profit Margin | 0.0359 | 0.0404 |
|
| |||||
| Pretax Profit Margin | 0.0377 | 0.0424 |
|
|
For Minerva Neurosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Minerva Neurosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Minerva Neurosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Minerva Neurosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Minerva Neurosciences over time as well as its relative position and ranking within its peers.
The next projected EPS of Minerva Neurosciences is estimated to be -0.14 with future projections ranging from a low of -0.14 to a high of -0.14. Minerva Neurosciences' most recent 12-month trailing earnings per share (EPS TTM) is at -1.85. Please be aware that the consensus of earnings estimates for Minerva Neurosciences is based on EPS before non-recurring items and includes expenses related to employee stock options. Minerva Neurosciences Earnings Estimation Breakdown
The calculation of Minerva Neurosciences' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Minerva Neurosciences is estimated to be -0.14 with the future projection ranging from a low of -0.14 to a high of -0.14. Please be aware that this consensus of annual earnings estimates for Minerva Neurosciences is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.14 Lowest | Expected EPS | -0.14 Highest |
Minerva Neurosciences Earnings Projection Consensus
Suppose the current estimates of Minerva Neurosciences' value are higher than the current market price of the Minerva Neurosciences stock. In this case, investors may conclude that Minerva Neurosciences is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Minerva Neurosciences' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 2 | 53.84% | 0.0 | -0.14 | -1.85 |
Minerva Neurosciences Earnings per Share Projection vs Actual
Minerva Neurosciences Ownership Allocation
The market capitalization of Minerva Neurosciences is $26.92 Million. Minerva Neurosciences holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.Minerva Neurosciences Profitability Analysis
Net Income was 1.44 M with loss before overhead, payroll, taxes, and interest of (5.57 M).About Minerva Neurosciences Valuation
Our relative valuation model uses a comparative analysis of Minerva Neurosciences. We calculate exposure to Minerva Neurosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Minerva Neurosciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -25.8 K | -24.5 K | |
| Pretax Profit Margin | 0.04 | 0.04 | |
| Operating Profit Margin | 0.04 | 0.04 | |
| Net Profit Margin | 0.04 | 0.04 |
Minerva Neurosciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Minerva Neurosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 7.6 M | |
| Forward Price Earnings | 11.2108 |
Minerva Neurosciences Current Valuation Indicators
Minerva Neurosciences' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Minerva Neurosciences' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Minerva Neurosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Minerva Neurosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Minerva Neurosciences' worth.Additional Tools for Minerva Stock Analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.